-
Company Insights
Innovation and Patenting activity of Medpace Holdings Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Medpace Holdings Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Ventilator Associated Pneumonia (VAP) Clinical Trials Market Report Overview The Ventilator Associated Pneumonia (VAP) clinical trial market research report provides an overview of Ventilator Associated Pneumonia Clinical trials scenario. This report provides top-line data relating to the clinical trials on Ventilator Associated Pneumonia. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Company Profile
Medpace Holdings Inc – Company Profile
Medpace Holdings Inc (Medpace) is a clinical research organization that provides outsourced clinical development services. It provides full-service Phase I to Phase IV clinical trial services, project management, regulatory affairs, data management, clinical monitoring, and post-market clinical support. The company also provides clinical human pharmacology, bio-analytical laboratory services, electrocardiography reading support, and various imaging services. Medpace carries out clinical trials of products for various conditions in cardiology, metabolic disease, endocrinology, central nervous system (CNS), oncology, and antiviral and anti-infective (AVAI)....
Add to Basket -
Product Insights
Tinnitus – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Tinnitus - Global Clinical Trials Review, H2, 2021" provides an overview of Tinnitus Clinical trials scenario. This report provides top line data relating to the clinical trials on Tinnitus . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Tachycardia (Tachyarrhythmias) – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021" provides an overview of Tachycardia (Tachyarrhythmias) Clinical trials scenario. This report provides top line data relating to the clinical trials on Tachycardia (Tachyarrhythmias). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...